Bath & Body Works, Inc.

As of July 31, 2026, Bath & Body Works, Inc. carries a market capitalization of 3.51B, placing it among publicly traded companies globally. Its enterprise value stands at 6.94B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bath & Body Works, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of July 31, 2026, Bath & Body Works, Inc. has 201.56M shares outstanding.

As of July 31, 2026, Bath & Body Works, Inc. trades at a trailing price-to-earnings ratio of 5.20. The price-to-sales ratio is 0.56, and the price-to-book ratio stands at -3.83.

As of July 31, 2026, Bath & Body Works, Inc. trades at an EV/EBITDA multiple of 5.50 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.63 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Bath & Body Works, Inc. trades at an EV/FCF ratio of 5.37, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 6.94B versus a market cap of 3.51B, with the gap driven by net debt and cash on the balance sheet.

As of July 31, 2026, Bath & Body Works, Inc. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -450.09, indicating conservative leverage, while an interest coverage ratio of 5.42 demonstrates adequate ability to service its debt obligations.

These figures cover the twelve months ended July 31, 2026. Return on invested capital (ROIC) comes in at 27.10 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 15.67, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.93, useful for judging operating efficiency across full business cycles. The company generates approximately 103,597.74 in revenue per employee across its workforce of 60,353.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.33 indicates how many times Bath & Body Works, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended July 31, 2026, Bath & Body Works, Inc. recorded 164.77M in income tax expense. That works out to an effective tax rate of 19.57, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 842.05M, leaving 677.28M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Bath & Body Works, Inc.'s stock has declined approximately 15.01% over the past 52 weeks. The 50-day moving average sits at 15.98, while the 200-day moving average is 17.11.

Over the twelve months ended July 31, 2026, Bath & Body Works, Inc. generated 6.25B in revenue and converted that into 677.28M in net income, yielding earnings per share of 3.33. EBITDA reached 1.26B, while operating income came in at 1.05B.

As of July 31, 2026, Bath & Body Works, Inc. holds 688.56M in cash and equivalents against 4.11B in total debt, resulting in a net debt position of 2.45B. Total book value stands at -915.76M, with working capital of 297.45M providing operational flexibility.

Bath & Body Works, Inc. produced 1.10B in operating cash flow over the twelve months ended July 31, 2026.

Over the twelve months ended July 31, 2026, Bath & Body Works, Inc. posted a gross margin of 44.12, reflecting its pricing power and cost economics. The operating margin of 16.74 and net profit margin of 10.83 provide insight into operational efficiency.

Over the twelve months ended July 31, 2026, Bath & Body Works, Inc. paid dividends of 0.69 per share. The dividend payout ratio of 20.74 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 31.20, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 15.35, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Bath & Body Works, Inc. shareholders.

Bath & Body Works, Inc.'s most recent stock split took place on May 31, 2000 with a 1:2 split ratio.

As of July 31, 2026, Bath & Body Works, Inc. has an Altman Z-Score of 2.66, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.